| ［1］ |
Huang ZQ, Fu FY, Li WL, et al. Current treatment modalities for osteonecrosis of femoral head in mainland China: a cross-sectional study［J］. Orthop Surg, 2020, 12（6）: 1776-1783.
|
| ［2］ |
刘君政, 周俊鹏, 李永伟, 等. 2003—2022年股骨头坏死研究的全球趋势［J］. 中华骨与关节外科杂志, 2023, 16（2）: 138-145.
|
| ［3］ |
Zhao D, Zhang F, Wang B, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults（2019 version）［J］. J Orthop Translat, 2020, 21: 100-110.
|
| ［4］ |
Solomon L. Clinical and therapeutic concepts in ischemic femur head necrosis［J］. Orthopade, 1990, 19（4）: 200-207.
|
| ［5］ |
Yoon BH, Jones LC, Chen CH, et al. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 1: glucocorticoid-associated osteonecrosis［J］. J Arthroplasty, 2019, 34（1）: 163-168.e1.
|
| ［6］ |
Yoon BH, Jones LC, Chen CH, et al. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 2: alcohol-associated osteonecrosis［J］. J Arthroplasty, 2019, 34（1）: 169-174.e1.
|
| ［7］ |
Cui Q, Wang GJ, Balian G. Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice［J］. Connect Tissue Res, 2000, 41（1）: 45-56.
|
| ［8］ |
郭坤亮. 内源性糖皮质激素在酒精性股骨头缺血坏死发病机制中的作用［D］. 重庆: 重庆医科大学, 2003.
|
| ［9］ |
Phemister DB. Bone growth and repair［J］. Ann Surg, 1935, 102（2）: 261-285.
|
| ［10］ |
Li H, Borinskaya S, Yoshimura K, et al. Refined geographic distribution of the oriental ALDH2*504Lys（nee 487Lys）variant［J］. Ann Hum Genet, 2009, 73（Pt 3）: 335-345.
|
| ［11］ |
Kubo T, Ueshima K, Saito M, et al. Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan［J］. J Orthop Sci, 2016, 21（4）: 407-413.
|
| ［12］ |
|
| ［13］ |
Mont MA, Cherian JJ, Sierra RJ, et al. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update［J］. J Bone Joint Surg Am, 2015, 97（19）: 1604-1627.
|
| ［14］ |
Kubo Y, Drescher W, Fragoulis A, et al. Adverse effects of oxidative stress on bone and vasculature in corticosteroid-associated osteonecrosis: potential role of nuclear factor erythroid 2-related factor 2 in cytoprotection［J］. Antioxid Redox Signal, 2021, 35（5）: 357-376.
|
| ［15］ |
Betteridge DJ. What is oxidative stress?［J］. Metabolism, 2000, 49（2）: 3-8.
|
| ［16］ |
Kim T-H, Hong JM, Oh B, et al. Genetic association study of polymorphisms in the catalase gene with the risk of osteonecrosis of the femoral head in the Korean population［J］. Osteoarthritis Cartilage, 2008, 16（9）: 1060-1066.
|
| ［17］ |
Ichiseki T, Matsumoto T, Nishino M, et al. Oxidative stress and vascular permeability in steroid-induced osteonecrosis model［J］. J Orthop Sci, 2004, 9（5）: 509-515.
|
| ［18］ |
Ichiseki T, Kaneuji A, Katsuda S, et al. DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis［J］. Rheumatology, 2005, 44（4）: 456-460.
|
| ［19］ |
Okura T, Seki T, Suzuki K, et al. Serum levels of carotenoids in patients with osteonecrosis of the femoral head are lower than in healthy, community-living people［J/OL］. J Orthop Surg, 2018, 26（2）: 2309499018770927. DOI: 10.1177/2309499018770927.
|
| ［20］ |
Chen K, Liu Y, He J, et al. Steroid-induced osteonecrosis of the femoral head reveals enhanced reactive oxygen species and hyperactive osteoclasts［J］. Int J Biol Sci, 2020, 16（11）: 1888-1900.
|
| ［21］ |
Vasiliou V, Pappa A, Estey T. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism［J］. Drug Metab Rev, 2004, 36（2）: 279-299.
|
| ［22］ |
Oyama T, Isse T, Kagawa N, et al. Tissue-distribution of aldehyde dehydrogenase 2 and effects of the ALDH2 gene-disruption on the expression of enzymes involved in alcohol metabolism［J］. Front Biosci, 2005, 10: 951-960.
|
| ［23］ |
Seamon J, Keller T, Saleh J, et al. The pathogenesis of nontraumatic osteonecrosis［J/OL］. Arthritis, 2012, 2012: 601763. DOI: 10.1155/2012/601763.
|
| ［24］ |
Prieto-Alhambra D, Turkiewicz A, Reyes C, et al. Smoking and alcohol intake but not muscle strength in young men increase fracture risk at middle age: a cohort study linked to the Swedish national patient registry［J］. J Bone Miner Res, 2020, 35（3）: 498-504.
|
| ［25］ |
Nielsen HK, Lundby L, Rasmussen K, et al. Alcohol decreases serum osteocalcin in a dose-dependent way in normal subjects［J］. Calcif Tissue Int, 1990, 46（3）: 173-178.
|
| ［26］ |
Rico H, Cabranes JA, Cabello J, et al. Low serum osteocalcin in acute alcohol intoxication: a direct toxic effect of alcohol on osteoblasts［J］. Bone Miner, 1987, 2（3）: 221-225.
|
| ［27］ |
Friday KE, Howard GA. Ethanol inhibits human bone cell proliferation and function in vitro［J］. Metabolism, 1991, 40（6）: 562-565.
|
| ［28］ |
Giuliani N, Girasole G, Vescovi PP, et al. Ethanol and acetaldehyde inhibit the formation of early osteoblast progenitors in murine and human bone marrow cultures［J］. Alcohol Clin Exp Res, 1999, 23（2）: 381-385.
|
| ［29］ |
Li L, Ding Y, Liu B, et al. Transcriptome landscape of the late-stage alcohol-induced osteonecrosis of the human femoral head［J/OL］. Bone, 2021, 150: 116012. DOI: 10.1016/j.bone.2021.116012.
|
| ［30］ |
Chen CH, Kraemer BR, Lee L, et al. Annotation of 1350 common genetic variants of the 19 ALDH multigene family from global human genome aggregation database（gnomAD）［J/OL］. Biomolecules, 2021, 11（10）: 1423. DOI: 10.3390/biom11101423.
|
| ［31］ |
Vasiliou V, Nebert DW. Analysis and update of the human aldehyde dehydrogenase（ALDH）gene family［J］. Hum Genomics, 2005, 2（2）: 138-143.
|
| ［32］ |
Stewart MJ, Malek K, Crabb DW. Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues［J］. J Investig Med, 1996, 44（2）: 42-46.
|
| ［33］ |
Ma H, Li J, Gao F, et al. Aldehyde dehydrogenase 2 ameliorates acute cardiac toxicity of ethanol: role of protein phosphatase and forkhead transcription factor［J］. J Am Coll Cardiol, 2009, 54（23）: 2187-2196.
|
| ［34］ |
Luckey SW, Petersen DR. Metabolism of 4-hydroxynonenal by rat kupffer cells［J］. Arch Biochem Biophys, 2001, 389（1）: 77-83.
|
| ［35］ |
Ohsawa I, Nishimaki K, Yasuda C, et al. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells［J］. J Neurochem, 2003, 84（5）: 1110-1117.
|
| ［36］ |
Vasiliou V, Pappa A. Polymorphisms of human aldehyde dehydrogenases［J］. Pharmacology, 2000, 61（3）: 192-198.
|
| ［37］ |
Brooks PJ, Enoch MA, Goldman D, et al. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption［J/OL］. PLoS Med, 2009, 6（3）: e1000050. DOI: 10.1371/journal.pmed.1000050.
|
| ［38］ |
Rizzo WB, Carney G. Sjögren-Larsson syndrome: Diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene（ALDH3A2）［J］. Hum Mutat, 2005, 26（1）: 1-10.
|
| ［39］ |
Kaur R, Paria P, Saini AG, et al. Metabolic epilepsy in hyperprolinemia type II due to a novel nonsense ALDH4A1 gene variant［J］. Metab Brain Dis, 2021, 36（6）: 1413-1417.
|
| ［40］ |
Motte J, Fisse AL, Grüter T, et al. Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis［J/OL］. BMC Neurol, 2019, 19（1）: 345. DOI: 10.1186/s12883-019-1583-0.
|
| ［41］ |
Lowe ED, Gao GY, Johnson LN, et al. Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase［J］. J Med Chem, 2008, 51（15）: 4482-4487.
|
| ［42］ |
Larson HN, Weiner H, Hurley TD. Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase “Asian” variant［J］. J Biol Chem, 2005, 280（34）: 30550-30556.
|
| ［43］ |
Chen CH, Ferreira JCB, Joshi AU, et al. Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes’ toxicity［J/OL］. EBio Medicine, 2020, 55: 102753. DOI: 10.1016/j.ebiom.2020.102753.
|
| ［44］ |
Hoshi H, Hao W, Fujita Y, et al. Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis［J］. J Bone Miner Res, 2012, 27（9）: 2015-2023.
|
| ［45］ |
Shimizu Y, Sakai A, Menuki K, et al. Reduced bone formation in alcohol-induced osteopenia is associated with elevated p21 expression in bone marrow cells in aldehyde dehydrogenase 2-disrupted mice［J］. Bone, 2011, 48（5）: 1075-1086.
|
| ［46］ |
Yamaguchi J, Hasegawa Y, Kawasaki M, et al. ALDH2 polymorphisms and bone mineral density in an elderly Japanese population［J］. Osteoporos Int, 2006, 17（6）: 908-913.
|
| ［47］ |
Okuma KF, Menuki K, Tsukamoto M, et al. Disruption of the aldehyde dehydrogenase 2 gene results in no increase in trabecular bone mass due to skeletal loading in association with impaired cell cycle regulation through p21 expression in the bone marrow cells of mice［J］. Calcif Tissue Int, 2017, 101（3）: 328-340.
|
| ［48］ |
Sakata R. A case-control study of association between life-style, alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotype and idiopathic osteonecrosis of the femoral head［J］. Kurume Med J, 2003, 50（3－4）: 121-130.
|
| ［49］ |
Ohta S, Ohsawa I, Kamino K, et al. Mitochondrial ALDH2 deficiency as an oxidative stress［J］. Ann N Y Acad Sci, 2004, 1011: 36-44.
|
| ［50］ |
Guo Y, Tan LJ, Lei SF, et al. Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis［J/OL］. PLoS Genet, 2010, 6（1）: e1000806. DOI: 10.1371/journal.pgen.1000806.
|
| ［51］ |
Perez-Miller S, Younus H, Vanam R, et al. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant［J］. Nat Struct Mol Biol, 2010, 17（2）: 159-164.
|
| ［52］ |
Lin X, Zhu D, Wang K, et al. Activation of aldehyde dehydrogenase 2 protects ethanol-induced osteonecrosis of the femoral head in rat model［J/OL］. Cell Prolif, 2022, 55（6）: e13252. DOI: 10.1111/cpr.13252.
|
| ［53］ |
Tsai SH, Hsu LA, Tsai HY, et al. Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells［J］. FASEB J, 2020, 34（7）: 9498-9511.
|